Prognostic significance of a solid component in pulmonary adenocarcinoma

Yoichi Ohtaki, Junji Yoshida, Genichiro Ishii, Keiju Aokage, Tomoyuki Hishida, Mitsuyo Nishimura, Izumi Takeyoshi, Kanji Nagai

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: We retrospectively analyzed pulmonary adenocarcinoma patient survival in our single-institution database to evaluate the impact of solid adenocarcinoma components (SAC) on survival and to propose a method of incorporating SAC into the T classification in future staging systems. Methods: We reviewed 504 consecutive patients with surgically resected pulmonary adenocarcinoma for their clinicopathologic characteristics and prognoses, stratifying patients according to predominant adenocarcinoma subtype. We also stratified patients with an SAC-containing tumor according to the ratio of SAC in analyzing outcome. Results: Patients with SAC (SAC+) had significantly poorer prognoses than patients without any SAC (SAC-), irrespective of SAC ratio. Patient groups stratified by pathologic T classification up to T2b could be divided into four categories according to SAC status in decreasing order of survival: (I) T1a/SAC-; (II) T1b/SAC-; (III) T1a/SAC+, T1b/SAC+, and T2a/SAC-; and (IV) T2a/SAC+ and T2b/SAC-. Conclusions: Pulmonary adenocarcinoma patients with any amount of SAC had worse prognoses than those without any SAC. The presence of SAC was an independent unfavorable prognostic factor, comparable to other pathologic findings indicating invasion. Solid adenocarcinoma component was an upstaging factor in T classification for T1 and T2a pulmonary adenocarcinomas. If SAC is present, we propose T1 and T2a tumors should be classified as T2a and T2b, respectively.

Original languageEnglish
Pages (from-to)1051-1057
Number of pages7
JournalAnnals of Thoracic Surgery
Volume91
Issue number4
DOIs
Publication statusPublished - 2011 Apr
Externally publishedYes

Fingerprint

Adenocarcinoma
Adenocarcinoma of lung
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Ohtaki, Y., Yoshida, J., Ishii, G., Aokage, K., Hishida, T., Nishimura, M., ... Nagai, K. (2011). Prognostic significance of a solid component in pulmonary adenocarcinoma. Annals of Thoracic Surgery, 91(4), 1051-1057. https://doi.org/10.1016/j.athoracsur.2010.11.071

Prognostic significance of a solid component in pulmonary adenocarcinoma. / Ohtaki, Yoichi; Yoshida, Junji; Ishii, Genichiro; Aokage, Keiju; Hishida, Tomoyuki; Nishimura, Mitsuyo; Takeyoshi, Izumi; Nagai, Kanji.

In: Annals of Thoracic Surgery, Vol. 91, No. 4, 04.2011, p. 1051-1057.

Research output: Contribution to journalArticle

Ohtaki, Y, Yoshida, J, Ishii, G, Aokage, K, Hishida, T, Nishimura, M, Takeyoshi, I & Nagai, K 2011, 'Prognostic significance of a solid component in pulmonary adenocarcinoma', Annals of Thoracic Surgery, vol. 91, no. 4, pp. 1051-1057. https://doi.org/10.1016/j.athoracsur.2010.11.071
Ohtaki, Yoichi ; Yoshida, Junji ; Ishii, Genichiro ; Aokage, Keiju ; Hishida, Tomoyuki ; Nishimura, Mitsuyo ; Takeyoshi, Izumi ; Nagai, Kanji. / Prognostic significance of a solid component in pulmonary adenocarcinoma. In: Annals of Thoracic Surgery. 2011 ; Vol. 91, No. 4. pp. 1051-1057.
@article{0d4863b62eb74dbdaa904cd818e04d91,
title = "Prognostic significance of a solid component in pulmonary adenocarcinoma",
abstract = "Background: We retrospectively analyzed pulmonary adenocarcinoma patient survival in our single-institution database to evaluate the impact of solid adenocarcinoma components (SAC) on survival and to propose a method of incorporating SAC into the T classification in future staging systems. Methods: We reviewed 504 consecutive patients with surgically resected pulmonary adenocarcinoma for their clinicopathologic characteristics and prognoses, stratifying patients according to predominant adenocarcinoma subtype. We also stratified patients with an SAC-containing tumor according to the ratio of SAC in analyzing outcome. Results: Patients with SAC (SAC+) had significantly poorer prognoses than patients without any SAC (SAC-), irrespective of SAC ratio. Patient groups stratified by pathologic T classification up to T2b could be divided into four categories according to SAC status in decreasing order of survival: (I) T1a/SAC-; (II) T1b/SAC-; (III) T1a/SAC+, T1b/SAC+, and T2a/SAC-; and (IV) T2a/SAC+ and T2b/SAC-. Conclusions: Pulmonary adenocarcinoma patients with any amount of SAC had worse prognoses than those without any SAC. The presence of SAC was an independent unfavorable prognostic factor, comparable to other pathologic findings indicating invasion. Solid adenocarcinoma component was an upstaging factor in T classification for T1 and T2a pulmonary adenocarcinomas. If SAC is present, we propose T1 and T2a tumors should be classified as T2a and T2b, respectively.",
author = "Yoichi Ohtaki and Junji Yoshida and Genichiro Ishii and Keiju Aokage and Tomoyuki Hishida and Mitsuyo Nishimura and Izumi Takeyoshi and Kanji Nagai",
year = "2011",
month = "4",
doi = "10.1016/j.athoracsur.2010.11.071",
language = "English",
volume = "91",
pages = "1051--1057",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Prognostic significance of a solid component in pulmonary adenocarcinoma

AU - Ohtaki, Yoichi

AU - Yoshida, Junji

AU - Ishii, Genichiro

AU - Aokage, Keiju

AU - Hishida, Tomoyuki

AU - Nishimura, Mitsuyo

AU - Takeyoshi, Izumi

AU - Nagai, Kanji

PY - 2011/4

Y1 - 2011/4

N2 - Background: We retrospectively analyzed pulmonary adenocarcinoma patient survival in our single-institution database to evaluate the impact of solid adenocarcinoma components (SAC) on survival and to propose a method of incorporating SAC into the T classification in future staging systems. Methods: We reviewed 504 consecutive patients with surgically resected pulmonary adenocarcinoma for their clinicopathologic characteristics and prognoses, stratifying patients according to predominant adenocarcinoma subtype. We also stratified patients with an SAC-containing tumor according to the ratio of SAC in analyzing outcome. Results: Patients with SAC (SAC+) had significantly poorer prognoses than patients without any SAC (SAC-), irrespective of SAC ratio. Patient groups stratified by pathologic T classification up to T2b could be divided into four categories according to SAC status in decreasing order of survival: (I) T1a/SAC-; (II) T1b/SAC-; (III) T1a/SAC+, T1b/SAC+, and T2a/SAC-; and (IV) T2a/SAC+ and T2b/SAC-. Conclusions: Pulmonary adenocarcinoma patients with any amount of SAC had worse prognoses than those without any SAC. The presence of SAC was an independent unfavorable prognostic factor, comparable to other pathologic findings indicating invasion. Solid adenocarcinoma component was an upstaging factor in T classification for T1 and T2a pulmonary adenocarcinomas. If SAC is present, we propose T1 and T2a tumors should be classified as T2a and T2b, respectively.

AB - Background: We retrospectively analyzed pulmonary adenocarcinoma patient survival in our single-institution database to evaluate the impact of solid adenocarcinoma components (SAC) on survival and to propose a method of incorporating SAC into the T classification in future staging systems. Methods: We reviewed 504 consecutive patients with surgically resected pulmonary adenocarcinoma for their clinicopathologic characteristics and prognoses, stratifying patients according to predominant adenocarcinoma subtype. We also stratified patients with an SAC-containing tumor according to the ratio of SAC in analyzing outcome. Results: Patients with SAC (SAC+) had significantly poorer prognoses than patients without any SAC (SAC-), irrespective of SAC ratio. Patient groups stratified by pathologic T classification up to T2b could be divided into four categories according to SAC status in decreasing order of survival: (I) T1a/SAC-; (II) T1b/SAC-; (III) T1a/SAC+, T1b/SAC+, and T2a/SAC-; and (IV) T2a/SAC+ and T2b/SAC-. Conclusions: Pulmonary adenocarcinoma patients with any amount of SAC had worse prognoses than those without any SAC. The presence of SAC was an independent unfavorable prognostic factor, comparable to other pathologic findings indicating invasion. Solid adenocarcinoma component was an upstaging factor in T classification for T1 and T2a pulmonary adenocarcinomas. If SAC is present, we propose T1 and T2a tumors should be classified as T2a and T2b, respectively.

UR - http://www.scopus.com/inward/record.url?scp=79953073673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953073673&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2010.11.071

DO - 10.1016/j.athoracsur.2010.11.071

M3 - Article

VL - 91

SP - 1051

EP - 1057

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -